Oncology

Multiple Myeloma

Advertisement
The Assessment of Measurable Residual Disease in Multiple Myeloma
Multiple Myeloma

The Assessment of Measurable Residual Disease in Multiple Myeloma

clinical topic updates
By Rafat Abonour, MD
Expert Roundtables Podcast: Defining the Needs of Today’s Patients With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma

Expert Roundtables Podcast: Defining the Needs of Today’s Patients With Relapsed/Refractory Multiple Myeloma

expert roundtables
By David E. Avigan, MD; Irene M. Ghobrial, MD; Saad Z. Usmani, MBBS, MD, MBA, FACP, FRCP, FASCO
Toxicity-Sparing Strategies and Supportive Care in Relapsed Multiple Myeloma
Multiple Myeloma

Toxicity-Sparing Strategies and Supportive Care in Relapsed Multiple Myeloma

expert roundtables
By David E. Avigan, MD; Irene M. Ghobrial, MD; Saad Z. Usmani, MBBS, MD, MBA, FACP, FRCP, FASCO
Maintaining Hope While Facing Multiply Refractory Multiple Myeloma
Multiple Myeloma

Maintaining Hope While Facing Multiply Refractory Multiple Myeloma

patient care perspectives
By David E. Avigan, MD
Maintenance Strategies in the Posttransplant Setting
Multiple Myeloma

Maintenance Strategies in the Posttransplant Setting

clinical topic updates
By David E. Avigan, MD
Load More   

Experts in Multiple Myeloma

+8

Meet the Experts   

Advertisement